Related Experiment Video
Updated: May 24, 2026

Murine Echocardiography of Left Atrium, Aorta, and Pulmonary Artery
Published on: February 20, 2017
Accumulation of pericardial fat correlates with left ventricular diastolic dysfunction in patients with normal
Masaaki Konishi1, Seigo Sugiyama, Koichi Sugamura
1Department of Cardiovascular Medicine, Kumamoto University, Kumamoto, Japan.
Insights
Increased pericardial fat (PF) is linked to left ventricular diastolic dysfunction (LVDD) in patients with preserved ejection fraction. This association persists even when accounting for other risk factors like obesity and diabetes.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Obesity Research
Background:
- Left ventricular diastolic dysfunction (LVDD) is a key factor in heart failure with preserved ejection fraction (HFpEF).
- Obesity is a significant comorbidity associated with LVDD.
- Pericardial fat (PF) may influence myocardial function and coronary circulation through paracrine or mechanical effects.
Purpose of the Study:
- To investigate the association between pericardial fat (PF) volume and left ventricular diastolic dysfunction (LVDD).
- To determine if PF is an independent predictor of LVDD in patients with normal left ventricular ejection fraction (LVEF).
Main Methods:
- Computed tomography was used to measure PF volume in 229 patients with suspected coronary artery disease and LVEF > 50%.
- Echocardiographic parameters, including the E/e' ratio, were analyzed to diagnose LVDD.
- Multivariate logistic regression was employed to assess the independence of the association between PF and LVDD.
Main Results:
- PF volume showed significant correlations with E/e' (r=0.21, p<0.01), left ventricular mass index (r=0.23, p<0.001), and left atrial diameter (r=0.32, p<0.001).
- Patients with LVDD had significantly greater mean PF volume (184±61 cm³) compared to those without LVDD (154±58 cm³, p<0.001).
- Increased PF volume was independently associated with the presence of LVDD (OR: 2.00 per 100 cm³ increase, p=0.02).
Conclusions:
- Pericardial fat volume is significantly associated with left ventricular diastolic dysfunction in patients with normal LVEF.
- PF may play a role in the development of LVDD, independent of common risk factors like hypertension and diabetes.
Background:
Left ventricular diastolic dysfunction (LVDD) plays an important role in heart failure with normal left ventricular ejection fraction (LVEF). Obesity is one of the major comorbid conditions of LVDD. Pericardial fat (PF) is an ectopic fat depot with possible paracrine or mechanical effects on the coronary circulation and myocardial function.
Methods:
We measured PF volume on 64 slice computed tomography and analyzed echocardiographic parameters to confirm LVDD in 229 consecutive patients suspected of coronary artery disease with LVEF of more than 50% and no symptomatic heart failure (59% men, 67±12 years). LVDD was defined as the ratio of transmitral Doppler early filling velocity to tissue Doppler early diastolic mitral annular velocity (E/e') >10.
Results:
PF volume correlated significantly with E/e' (r=0.21, p<0.01), left ventricular mass index (r=0.23, p<0.001), and left atrial diameter (r=0.32, p<0.001). The mean PF volume was significantly greater in patients with LVDD (184±61cm(3), n=141) than in those without LVDD (154±58, n=88, p<0.001). Multivariate logistic regression analysis indicated that PF volume correlated significantly with the presence of LVDD (odds ratio: 2.00 per 100cm(3) increase in PF volume, p=0.02) independent of age, gender, abdominal obesity, hypertension, and diabetes.
Conclusions:
PF volumes are significantly associated with LVDD, independent of other factors such as hypertension or diabetes. PF may be implicated in the pathogenesis of LVDD in patients with normal LVEF.
Related Concept Videos
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure